Experimental Drug MnTBAP Shows Promise in Preventing Cisplatin-Induced Hearing Loss in Mice
Researchers found that the compound MnTBAP protected against hearing loss caused by cisplatin, a widely-used chemotherapy drug, in mouse studies. Cisplatin causes ototoxicity through oxidative stress mechanisms, and currently only sodium thiosulfate is approved to prevent this side effect in pediatric patients. The findings suggest MnTBAP could become a new therapeutic option for patients undergoing cisplatin treatment who face permanent hearing damage.
In a preclinical study published on bioRxiv, researchers demonstrated that MnTBAP, a manganese-based compound, protected hearing in mice treated with cisplatin chemotherapy. The study used auditory testing and microscopic analysis to show that cisplatin damages hair cells and nerve cells in the cochlea through oxidative stress, elevating nitrotyrosine levels and causing permanent hearing loss. When MnTBAP was administered alongside cisplatin, it prevented these cellular changes and preserved normal hearing thresholds and auditory function. The findings are significant because cisplatin is an effective cancer treatment but causes irreversible hearing damage in many patients, and currently few preventive options exist beyond sodium thiosulfate in pediatric cases. The researchers conclude MnTBAP warrants further investigation as a potential clinical intervention.
What's missing
The article does not discuss whether MnTBAP has been tested in human subjects, what its safety profile is, or how it compares to sodium thiosulfate in efficacy. Additionally, there is no mention of the timeline for potential clinical trials or regulatory approval pathways.
How coverage differed
This is a preprint from bioRxiv, which presents preliminary research findings before peer review. The source maintains neutral scientific language typical of research abstracts, though the conclusion emphasizes therapeutic potential, which is standard for studies proposing new treatments.
What different sources said
- bioRxivCenter
Otoprotective effect of MnTBAP in cisplatin-induced hearing loss
Related
Study reveals complex DNA repair pathway interactions in radiation-resistant bacterium
Researchers discovered that Deinococcus radiodurans uses interacting DNA repair pathways to achieve exceptional radiation resistance. The study identified direct protein interactions between nucleotide excision repair (NER) and base excision repair (BER) pathways that work together to remove DNA damage. This finding may explain how the bacterium survives extreme radiation and could inform strategies for protecting cells from radiation damage.
Researchers Develop Human-Derived Hydrogel Platform for Osteochondral Tissue Repair
Scientists created granular extracellular matrix (gECM) hydrogels derived from human donor tissues that can be tailored for cartilage and bone repair. The hydrogels maintain tissue-specific properties and mechanical characteristics suitable for clinical use. This advancement addresses a significant clinical challenge in treating osteochondral defects where cartilage has limited regenerative capacity.
Widespread US Heat Wave Brings Dangerous Temperatures Across Multiple Regions
A significant heat wave is spreading across the central United States with heat index values forecast to exceed 110 degrees in parts of Texas and 100 degrees across multiple states including Missouri, Kansas, Iowa, Arkansas, and Tennessee. The National Weather Service warns that early-season heat waves pose greater risks for heat-related illness and could break daily temperature records across numerous states. The extreme heat is expected to impact more than 20 cities, with temperatures 10-20 degrees above normal in some regions, particularly the Upper Midwest and Great Lakes area.